Therapy News and Research

RSS

NIH researchers show how investigational drug works against rare, fatal genetic disease

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

17 Jul 2017

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

Moffitt Cancer Center researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery (neoadjuvant) or after surgery (adjuvant).

17 Jul 2017

Black light helps determine disease extent of melasma in pregnant women

Researchers at Boston Medical Center and Boston University School of Medicine have found that using a black light, or Wood's light, helps dermatologists determine disease extent of melasma, a hyperpigmentation condition that causes brown and gray patches to appear on the face.

17 Jul 2017

'Organic gene therapy' could be effective treatment approach for serious blood disorders

Genome therapy with beneficial natural mutation could lead to new treatment for life-threatening blood disorders.

17 Jul 2017

Lymph node removal may not be needed for all melanoma patients, study finds

Many patients with melanoma need a sentinel-lymph-node biopsy to determine if cancer cells have spread there, but a positive finding doesn't mean all the lymph nodes in the area must be removed, according to new international study.

17 Jul 2017

Combining care program with drug reduces damaging effects of Alzheimer's disease

Combining a specific care management program with a commonly-prescribed drug for Alzheimer's disease multiplies the medication's ability to improve daily function by about 7.5 times, stalling some of the disease's most damaging effects.

17 Jul 2017

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.

17 Jul 2017

Clear recommendations can be given only for few stutter therapies, say experts

About 1% of children and adolescents, 0.2% of women, and 0.8% of men suffer from stuttering. However, based on the available studies, clear recommendations can be given only for a few of the currently available stutter therapies.

14 Jul 2017

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels.

14 Jul 2017

Fermented red clover extract decreases number and severity of menopausal hot flushes

The vast majority of women in the menopause are familiar with the status of Red Clover as an herbal medicine that soothes hot flush symptoms and hormonal fluctuations.

14 Jul 2017

Scientists uncover new gene therapy treatment routes for motor neurone disease

Scientists investigating the genetic causes and altered functioning of nerve cells in motor neurone disease (MND) have discovered a new mechanism that could lead to fresh treatment approaches for one of the most common forms of the disease.

14 Jul 2017

LSTM awarded £11 million by NIHR to establish new research unit and groups

LSTM has been awarded £11 million by the National Institute for Health Research as part of their latest UK-wide call for funding into Global Health Research Units.

14 Jul 2017

Scientists uncover new group of Treg cells and DNA features linked to juvenile idiopathic arthritis

A team of scientists and doctors from the SingHealth Duke-NUS Academic Medical Centre has uncovered a new group of regulatory T (Treg) cells and DNA features associated with juvenile idiopathic arthritis (JIA), the most common form of arthritis among children under the age of 16.

14 Jul 2017

BWH researchers use specific microRNA to identify, alter makeup of glioblastoma subtypes

Glioblastoma multiforme (GBM), an extremely aggressive brain cancer, is a very complex disease. It is characterized by a fast-growing tumor in the brain composed of many subpopulations of cells, including glioblastoma stem cells, which play a crucial role in glioblastoma initiation, expansion and therapy-resistance.

14 Jul 2017

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient’s own genes would be modified to fight the cancer cells. The patient’s cells which are thus altered to treat the cancer would thus be termed as “living drugs” as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

14 Jul 2017

Therapy News and Research

NIH researchers show how investigational drug works against rare, fatal genetic disease

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

Black light helps determine disease extent of melasma in pregnant women

'Organic gene therapy' could be effective treatment approach for serious blood disorders

Lymph node removal may not be needed for all melanoma patients, study finds

Combining care program with drug reduces damaging effects of Alzheimer's disease

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

Clear recommendations can be given only for few stutter therapies, say experts

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

Fermented red clover extract decreases number and severity of menopausal hot flushes

Scientists uncover new gene therapy treatment routes for motor neurone disease

LSTM awarded £11 million by NIHR to establish new research unit and groups

Scientists uncover new group of Treg cells and DNA features linked to juvenile idiopathic arthritis

BWH researchers use specific microRNA to identify, alter makeup of glioblastoma subtypes

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

Beaumont Health's new Proton Therapy Center starts treating cancer patients

New stent technology could help preserve vision, reduce risks in glaucoma patients

Transgender health care targeted in crusade to undo ACA

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

ASTRO releases updated insurance coverage recommendations for proton beam therapy to treat cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News